Literature DB >> 24447735

Circulating serum levels of growth differentiation factor-15 and neuregulin-1 in patients with paroxysmal non-valvular atrial fibrillation.

Qingmiao Shao1, Hongmei Liu1, Chee Yuan Ng2, Gang Xu1, Enzhao Liu1, Guangping Li3, Tong Liu4.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Biomarker; Growth differentiation factor-15; Neuregulin-1

Mesh：

Substances：

Year:  2014        PMID： 24447735     DOI： 10.1016/j.ijcard.2013.12.173

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  9 in total

Review 1.  Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke.

Authors:  István Szegedi; László Szapáry; Péter Csécsei; Zoltán Csanádi; László Csiba
Journal:  Biomed Res Int       Date:  2017-07-13       Impact factor: 3.411

2.  Effects of febuxostat on atrial remodeling in a rabbit model of atrial fibrillation induced by rapid atrial pacing.

Authors:  Yong-Yan Fan; Feng Xu; Chao Zhu; Wen-Kun Cheng; Jian Li; Zhao-Liang Shan; Yang Li; Yu-Tang Wang
Journal:  J Geriatr Cardiol       Date:  2019-07       Impact factor: 3.327

3.  The Predictive Value of Growth Differentiation Factor-15 in Recurrence of Atrial Fibrillation after Catheter Ablation.

Authors:  Ying Wei; Shuwang Liu; Haiyi Yu; Yuan Zhang; Wei Gao; Ming Cui; Lei Li
Journal:  Mediators Inflamm       Date:  2020-08-21       Impact factor: 4.711

4.  Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis.

Authors:  Ziqi Tan; Tiangang Song; Shanshan Huang; Menglu Liu; Jianyong Ma; Jing Zhang; Peng Yu; Xiao Liu
Journal:  Front Cardiovasc Med       Date:  2022-08-04

5.  Plasma growth differentiation factor-15 in patients with "lone" atrial fibrillation.

Authors:  Na Li; Qian Feng; Fangfang Yu; Jian Zhou; Xueyuan Guo
Journal:  J Clin Lab Anal       Date:  2022-03-25       Impact factor: 3.124

Review 6.  Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.

Authors:  Nicolas Clementy; Eric Piver; Arnaud Bisson; Clémentine Andre; Anne Bernard; Bertrand Pierre; Laurent Fauchier; Dominique Babuty
Journal:  Int J Mol Sci       Date:  2018-03-25       Impact factor: 5.923

7.  Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation.

Authors:  Xiaoya Zhou; Zhuo Wang; Bing Huang; Shenxu Yuan; Xia Sheng; Lilei Yu; Guannan Meng; Yuhong Wang; Sunny S Po; Hong Jiang
Journal:  Front Physiol       Date:  2018-08-21       Impact factor: 4.566

Review 8.  Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease.

Authors:  Andrew Geissler; Sergey Ryzhov; Douglas B Sawyer
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876

9.  The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.

Authors:  Zhuo Wang; Fangkun Yang; Menghuai Ma; Qinyi Bao; Jinlian Shen; Feiming Ye; Xiaojie Xie
Journal:  BMC Cardiovasc Disord       Date:  2020-10-28       Impact factor: 2.298
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.